Prokidney Corp 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 0.75, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Prokidney in Jun 30 2026 quarter, has decreased to 487 days, compared to 529 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 553 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 3359 to 3752.

What is Receivable Turnover Ratio?
What is Prokidney Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PROK Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-46.14 %	-41.1 %	-53.94 %	-75.75 %	-35.41 %
Y / Y Revenue Change	-32.13 %	-1.74 %	196.05 %	-	-
Receivable Turnover Ratio (TTM)	0.75	0.69	0.61	0.41	0.19
PROK's Total Ranking	# 3752	# 3359	# 3417	# 3612	# 0
Accounts Receivable average collection period days	485	531	602	884	1918
Seq. Receivable Change	-7.36 %	-8.43 %	-8.89 %	-30.31 %	1.31 %
Seq. Revenue Change	-33.63 %	0.44 %	3.69 %	-1.81 %	-3.91 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 70
Healthcare Sector	# 554
Overall Market	# 3752

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0
(Mar 31 2026)		(Sep 30 2025)

PROK Company Profile • Back to PROK Efficiency Comparisons • Compare PROK Receivables Turnover Ratio to its Competitors

Financial Statements
Prokidney 's Accounts Receivable	$ 1 Millions	Visit PROK's Balance sheet
Prokidney 's Sales TTM	$ 1 Millions	Visit PROK's Income Statement
Sources of PROK's Revenues		Visit PROK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PROK's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PROK's Growth Rates	PROK's Roa	PROK's Inventory Turnover Ratio	PROK's Dividend Comparisons
PROK's Profitability Ratios	PROK's Roi	PROK's Asset Turnover Ratio	PROK's Dividend Growth
PROK's Valuation Ratios	PROK's Roe	PROK's Financial Strength Ratios	PROK's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Arbutus Biopharma Corp	2.35	$ 181.720 Millions	$ 77.420 Millions
Tg Therapeutics Inc	2.34	$ 799.536 Millions	$ 341.156 Millions
Abcellera Biologics Inc	2.30	$ 66.174 Millions	$ 28.812 Millions
Cumberland Pharmaceuticals Inc	2.27	$ 31.269 Millions	$ 13.764 Millions
Co diagnostics Inc	2.14	$ 0.721 Millions	$ 0.337 Millions
Profound Medical Corp	2.14	$ 19.086 Millions	$ 8.924 Millions
60 Degrees Pharmaceuticals Inc	2.13	$ 1.111 Millions	$ 0.522 Millions
Cardio Diagnostics Holdings Inc	2.10	$ 0.014 Millions	$ 0.007 Millions
Scilex Holding Company	1.93	$ 31.608 Millions	$ 16.396 Millions
Ocular Therapeutix Inc	1.79	$ 52.054 Millions	$ 29.007 Millions
Heron Therapeutics Inc	1.76	$ 151.507 Millions	$ 85.975 Millions
Bio Green Med Solution Inc	1.75	$ 1.861 Millions	$ 1.061 Millions
EBR Systems, Inc.	1.74	$ 6.446 Millions	$ 3.714 Millions
Cytomx Therapeutics Inc	1.69	$ 18.302 Millions	$ 10.821 Millions
Biocorrx Inc	1.67	$ 0.787 Millions	$ 0.471 Millions
Prophase Labs Inc	1.59	$ 3.150 Millions	$ 1.977 Millions
Amarin Corp Plcuk	1.49	$ 186.480 Millions	$ 125.559 Millions
Skinvisible Inc	1.45	$ 0.020 Millions	$ 0.014 Millions
Lightwave Logic Inc	1.40	$ 0.250 Millions	$ 0.178 Millions
Roivant Sciences Ltd	1.39	$ 7.532 Millions	$ 5.400 Millions
Newamsterdam Pharma Company N v	1.15	$ 7.121 Millions	$ 6.167 Millions
Clene Inc	1.15	$ 0.197 Millions	$ 0.171 Millions
Instil Bio Inc	1.15	$ 8.968 Millions	$ 7.822 Millions
Scienture Holdings Inc	1.15	$ 0.821 Millions	$ 0.717 Millions
Regen Biopharma Inc	0.99	$ 0.237 Millions	$ 0.239 Millions
Prokidney Corp	0.75	$ 0.818 Millions	$ 1.088 Millions
Royalty Pharma Plc	0.50	$ 2,535.998 Millions	$ 5,116.482 Millions
Cardiff Lexington Corporation	0.46	$ 10.213 Millions	$ 22.347 Millions

Date modified: 2026-09-12T06:25:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.